5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.86%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.47%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-39.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-41.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-41.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
3.54%
Share count expansion well above METSB.HE's 3.54%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.54%
Diluted share count expanding well above METSB.HE's 3.54%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-15.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-54.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.54%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-7.94%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
20.17%
3Y revenue/share CAGR similar to METSB.HE's 20.17%. Walter Schloss would assume both companies experience comparable short-term cycles.
240.15%
10Y OCF/share CAGR in line with METSB.HE's 240.15%. Walter Schloss would see both as similarly efficient over the decade.
-68.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
247.30%
3Y OCF/share CAGR similar to METSB.HE's 247.30%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
134.89%
Similar net income/share CAGR to METSB.HE's 134.89%. Walter Schloss would see parallel tailwinds or expansions for both firms.
105.96%
5Y net income/share CAGR similar to METSB.HE's 105.96%. Walter Schloss might see both on parallel mid-term trajectories.
66.67%
3Y net income/share CAGR similar to METSB.HE's 66.67%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
46.50%
5Y equity/share CAGR is in line with METSB.HE's 46.50%. Walter Schloss would see parallel mid-term profitability and retention policies.
36.39%
3Y equity/share CAGR similar to METSB.HE's 36.39%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
233.14%
Similar 5Y dividend/share CAGR to METSB.HE's 233.14%. Walter Schloss sees parallel philosophies in mid-term capital returns.
81.82%
3Y dividend/share CAGR similar to METSB.HE's 81.82%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-3.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.73%
Inventory growth well above METSB.HE's 1.73%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.96%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.70%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
18.05%
Debt growth far above METSB.HE's 18.05%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.57%
SG&A growth well above METSB.HE's 9.57%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.